KWALITY PHARMACEUTICALS Financial Statement Analysis
|
||
The Revenues of KWALITY PHARMACEUTICALS have increased by 22.36% YoY .
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has increased by 22.82 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
KWALITY PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539997]
Consolidated | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
---|---|---|---|---|---|
Revenues | ₹307 Cr | ₹251 Cr | ₹456 Cr | ₹262 Cr | ₹139 Cr |
Expenses | ₹241 Cr | ₹190 Cr | ₹285 Cr | ₹233 Cr | ₹125 Cr |
Operating Profit (Excl OI) | ₹66 Cr | ₹61 Cr | ₹172 Cr | ₹29 Cr | ₹14 Cr |
Other Income | ₹1.83 Cr | ₹2.94 Cr | ₹3.51 Cr | ₹1.59 Cr | ₹3.66 Cr |
Interest | ₹10 Cr | ₹6.61 Cr | ₹2.92 Cr | ₹2.68 Cr | ₹2.50 Cr |
Depreciation | ₹20 Cr | ₹15 Cr | ₹11 Cr | ₹6.49 Cr | ₹4.43 Cr |
Profit Before Tax | ₹31 Cr | ₹26 Cr | ₹162 Cr | ₹21 Cr | ₹11 Cr |
Profit After Tax | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.21 Cr |
Consolidated Net Profit | ₹24 Cr | ₹19 Cr | ₹120 Cr | ₹15 Cr | ₹8.32 Cr |
Earnings Per Share (Rs) | ₹22.93 | ₹18.67 | ₹115.64 | ₹14.60 | ₹8.02 |
PAT Margin (%) | 7.69 | 7.68 | 26.29 | 5.68 | 5.89 |
ROE(%) | 11.16 | 10.15 | 99.66 | 28.21 | 20.10 |
ROCE(%) | 13.57 | 12.27 | 97.93 | 26.35 | 18.46 |
Total Debt/Equity(x) | 0.44 | 0.45 | 0.30 | 0.68 | 0.77 |
Key Financials |
||
Market Cap | : | ₹ 964.1 Cr |
Revenue (TTM) | : | ₹ 370.2 Cr |
Net Profit(TTM) | : | ₹ 39.8 Cr |
EPS (TTM) | : | ₹ 38.3 |
P/E (TTM) | : | 24.2 |
Industry Peers & Returns | 1W | 1M | 1Y |
KWALITY PHARMACEUTICALS | 1.4% | 25.6% | 75% |
SUN PHARMACEUTICAL INDUSTRIES | 0.3% | -4.9% | 15.8% |
DIVIS LABORATORIES | 0.2% | 10% | 53.5% |
CIPLA | 2.3% | 1.1% | 2.6% |
TORRENT PHARMACEUTICALS | 0.8% | -0.9% | 17.4% |
DR REDDYS LABORATORIES | 5.7% | 15% | 11.5% |
MANKIND PHARMA | -2.5% | -3.3% | 11.1% |
ZYDUS LIFESCIENCES | 3.3% | 10.1% | -7.4% |
LUPIN | 2% | -0.7% | 26% |
KWALITY PHARMACEUTICALS Revenues
[BOM: 539997]
Y-o-Y | 22.36 % |
5 Yr CAGR | 21.86 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2024 | ₹307 Cr | 22.36 | |
Mar2023 | ₹251 Cr | -44.97 | |
Mar2022 | ₹456 Cr | 74.11 | |
Mar2021 | ₹262 Cr | 88.10 | |
Mar2020 | ₹139 Cr | - |
KWALITY PHARMACEUTICALS Operating Profit
[BOM: 539997]
Y-o-Y | 9.20 % |
5 Yr CAGR | 47.02 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2024 | ₹66 Cr | 9.20 | |
Mar2023 | ₹61 Cr | -64.62 | |
Mar2022 | ₹172 Cr | 494.98 | |
Mar2021 | ₹29 Cr | 103.27 | |
Mar2020 | ₹14 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -10.75 % |
5 Yr CAGR | 20.65 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2024 | 21.59% | -10.75 | |
Mar2023 | 24.19% | -35.72 | |
Mar2022 | 37.63% | 241.78 | |
Mar2021 | 11.01% | 8.05 | |
Mar2020 | 10.19% | - |
KWALITY PHARMACEUTICALS Profit After Tax
[BOM: 539997]
Y-o-Y | 22.83 % |
5 Yr CAGR | 30.06 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹24 Cr | 22.83 | |
Mar2023 | ₹19 Cr | -83.85 | |
Mar2022 | ₹120 Cr | 692.23 | |
Mar2021 | ₹15 Cr | 82.11 | |
Mar2020 | ₹8.32 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 0.13 % |
5 Yr CAGR | 6.89 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2024 | 7.69 % | 0.13 | |
Mar2023 | 7.68 % | -70.79 | |
Mar2022 | 26.29 % | 362.85 | |
Mar2021 | 5.68 % | -3.57 | |
Mar2020 | 5.89 % | - |
KWALITY PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539997]
Y-o-Y | 22.82 % |
5 Yr CAGR | 30.03 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2024 | ₹23 | 22.82 | |
Mar2023 | ₹19 | -83.86 | |
Mar2022 | ₹116 | 692.05 | |
Mar2021 | ₹15 | 82.04 | |
Mar2020 | ₹8.02 | - |
KWALITY PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539997]
Y-o-Y | 10.59 % |
5 Yr CAGR | -7.41 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2024 | 13.57% | 10.59 | |
Mar2023 | 12.27% | -87.47 | |
Mar2022 | 97.93% | 271.65 | |
Mar2021 | 26.35% | 42.74 | |
Mar2020 | 18.46% | - |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Current Share Price | : | ₹927.0 |
Current MarketCap | : | ₹ 964.1 Cr |
Updated EOD on | : | Jun 06,2025 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | 1.4% |
25.6% |
75% |
SENSEX | 0.9% |
1.8% |
11.1% |
KWALITY PHARMACEUTICALS related INDICES
You may also like the below Video Courses
FAQ about KWALITY PHARMACEUTICALS Financials
How the annual revenues of KWALITY PHARMACEUTICALS have changed ?
The Revenues of KWALITY PHARMACEUTICALS have increased by 22.36% YoY .
How the Earnings per Share (EPS) of KWALITY PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has increased by 22.82 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs